BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 36028137)

  • 21. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined Age with Mean Decrease Rates of Total Bilirubin and MELD Score as a Novel and Simple Clinical Predictor on 90-Day Transplant-Free Mortality in Adult Patients with Acute Liver Failure Undergoing Plasma Exchange: A Single-Center Retrospective Study.
    Jin D; Kang K; Yan BZ; Zhang JN; Zheng JB; Wang ZH; Wu D; Tang YJ; Wang XT; Lai QQ; Cao Y; Wang HL; Gao Y
    Can J Gastroenterol Hepatol; 2023; 2023():6115499. PubMed ID: 38021269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
    Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UNOS Liver Registry: ten year survivals.
    Waki K
    Clin Transpl; 2006; ():29-39. PubMed ID: 18368704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing practice and acceptable outcomes of high-MELD living donor liver transplantation in the USA.
    Anouti A; Patel MS; VanWagner LB; Lee WM; Asrani SK; Mufti AR; Rich NE; Vagefi PA; Shah JA; Kerr TA; Pedersen M; Hanish S; Singal AG; Cotter TG
    Liver Transpl; 2024 Jan; 30(1):72-82. PubMed ID: 37490432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
    Wagener G; Raffel B; Young AT; Minhaz M; Emond J
    Liver Transpl; 2013 May; 19(5):534-42. PubMed ID: 23576469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of perceived donor liver quality on post-transplant outcome.
    Dirchwolf M; Becchetti C; Stampf S; Haldimann C; Immer F; Beyeler F; Toso C; Dutkowski P; Candinas D; Dufour JF; Banz V;
    ANZ J Surg; 2023 Apr; 93(4):918-925. PubMed ID: 36708059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of older deceased donors for pediatric liver transplant may negatively impact long-term survival.
    Kulkarni SS; Vachharajani NA; Hill AL; Kiani AZ; Stoll JM; Nadler ML; Chapman WC; Doyle MM; Khan AS
    J Pediatr Gastroenterol Nutr; 2024 Apr; 78(4):898-908. PubMed ID: 38591666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An explainable supervised machine learning predictor of acute kidney injury after adult deceased donor liver transplantation.
    Zhang Y; Yang D; Liu Z; Chen C; Ge M; Li X; Luo T; Wu Z; Shi C; Wang B; Huang X; Zhang X; Zhou S; Hei Z
    J Transl Med; 2021 Jul; 19(1):321. PubMed ID: 34321016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver Transplant Survival Index for Patients with Model for End-Stage Liver Disease Score ≥ 35: Modeling Risk and Adjusting Expectations in the Share 35 Era.
    Steggerda JA; Kim IK; Todo T; Malinoski D; Klein AS; Bloom MB
    J Am Coll Surg; 2019 Apr; 228(4):437-450.e8. PubMed ID: 30594593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival Benefit of Living-Donor Liver Transplant.
    Jackson WE; Malamon JS; Kaplan B; Saben JL; Schold JD; Pomposelli JJ; Pomfret EA
    JAMA Surg; 2022 Oct; 157(10):926-932. PubMed ID: 35921119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term].
    Boin Ide F; Leonardi MI; Udo EY; Sevá-Pereira T; Stucchi RS; Leonardi LS
    Arq Gastroenterol; 2008; 45(4):275-83. PubMed ID: 19148354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
    Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor and recipient factors predicting time to graft failure following orthotopic liver transplantation: a transplant risk index.
    Stey AM; Doucette J; Florman S; Emre S
    Transplant Proc; 2013; 45(6):2077-82. PubMed ID: 23953516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.